Congenital esophageal atresia (EA) with tracheoesophageal fistula (TEF) is principally corrected in the neonatal phase. Increasingly, the correction of atresia and closing of the fistula is performed via a thoracoscopic approach \[[@CR1]\]. A low-pressure carbon dioxide (CO~2~) pneumothorax (PT) environment collapses the right lung enough to visualize the atresic esophagus and TEF. The procedure is performed under permissive hypercapnic conditions \[[@CR2], [@CR3]\]. Recent literature addressing thoracoscopic procedures in neonates has specified some concerns regarding the extra CO~2~ load of applied PT with decreased venous return under elevated intrathoracic pressure. This may be hazardous to neonatal physiology \[[@CR4]\] and the developing central nervous system. In particular, impairment of cerebral oxygenation levels in neonates undergoing thoracoscopic procedures has been reported \[[@CR5]\].

During surgical procedures and at the patient bedside, neonatal brain hemodynamics and oxygenation can be assessed by transcranial near-infrared spectroscopy (tcNIRS). This tcNIRS permits continuous noninvasive monitoring over extended periods of time. Until now tcNIRS monitoring was not a standard procedure in most neonatal intensive care units (NICU)'s and in OR's during surgery of newborns. However, in recent years more information has become available concerning the relationship between low cerebral oxygenation monitored by NIRS and the occurrence of brain damage among newborns and young children \[[@CR6]--[@CR8]\]. Currently NIRS monitoring is routinely performed in our NICU and in our OR during thoracoscopic correction of EA. Thus far NIRS findings during thoracoscopic correction of EA of only two patients have been reported \[[@CR5]\]. The aim of the present study was to investigate tcNIRS in the perioperative period of neonates elected for minimally invasive EA reconstruction.

Methods {#Sec1}
=======

Guidelines and procedures for this investigation were reviewed and approved by the institutional Medical Ethics Committee of the University Medical Center Utrecht. Parents were informed about the study design and procedures, and informed parental consent was obtained from both parents of each participating neonate. This study was performed in compliance with the principles established in the Helsinki Declaration (version Fortaleza, October 19, 2013). NIRS monitoring is already used as a standard clinical monitoring tool in the NICU of the Wilhelmina Children's Hospital.

Patients {#Sec2}
--------

In this single-center prospective observational study, 15 patients diagnosed with EA with TEF (Type C atresia), admitted to the NICU of the Wilhelmina Children's Hospital of the University Medical Center Utrecht were enrolled between January 2012 and September 2014. Preoperative workup consisted of screening for associated anomalies (VACTERL) including ultrasound of the heart and aorta to exclude right descending aortic involvement. Before surgery arterial and venous lines were placed for monitoring blood pressure, arterial blood sampling, and venous access, respectively. A suction drain was placed in the proximal esophageal pouch to prevent aspiration.

Anesthesia {#Sec3}
----------

All patients were subjected to a standardized anesthesia protocol. For the induction of anesthesia sevoflurane (6--8 % inspired concentration) was used with a 40--100 % fraction of inspired oxygen (FiO~2~). After muscle relaxation with atracurium (0.5 mg/kg), the infants were tracheally intubated. Thoracoscopy was performed with both lungs ventilated. Anesthesia was maintained with sufentanil and an oxygen/air mixture and sevoflurane. During the procedure tcNIRS values and simultaneously monitored heart rate, blood pressure, arterial oxygen saturation (SaO~2~), and end tidal CO~2~ values were collected and stored in a high frequency rate (0.5 Hz) on a PC (Bedbase software, UMC Utrecht, NL). Every 30 min blood samples (blood gas; Hb) were taken as part of the routine clinical procedure during thoracoscopic neonatal surgery. The aim was to establish stable anesthetic conditions based on the rScO~2~, SaO~2~ values, end tidal CO~2~ values and blood gas analysis by adjustment of respiratory settings in frequency, maximum inspiratory pressure (Pmax) and FiO~2~. Hypotension was prevented with fluid expansion or inotropes. The CO~2~ gas insufflation was temporarily stopped if the applied PT caused insufficient ability to adequately ventilate the patient.

Surgery {#Sec4}
-------

All surgery was performed in the same operating theater with a stable room temperature of 22 ± 1 °C. In one patient rigid bronchoscopy was performed prior to surgery to assess possible concomitant tracheomalacia and to locate the TEF. The patients were placed in a left laterally recumbent position on a heated operating table (36 ± 1 °C) and tilted 10°--20° reverse Trendelenburg. All thoracoscopic EA repairs were performed through the right thoracic cavity according to earlier described techniques \[[@CR9]\]. In short, the PT was created through a 5-mm intercostal camera-trocar placed via an open incisional procedure. An intrathoracic pressure of 5 mmHg was achieved with a flow of 1 L/min insufflation with CO~2~. Two trocars were placed through two 3-mm wounds (one caudodorsal and one cranio-anterior from the camera-trocar). If necessary, an extra trocar was placed to manipulate the lung out of sight to maximize the operating field-of-view. The azygos vein was coagulated and transected when it blocked exposure of the TE junction; the TEF was subsequently ligated with a transfixing absorbable 4.0 Vicryl suture close to the trachea. After transection of the distal esophagus, the proximal pouch was opened. Finally, both ends of the esophagus were anastomosed with interrupted 5.0 absorbable Vicryl sutures over a nasogastric feeding tube.

Regional cerebral oxygenation {#Sec5}
-----------------------------

To measure rScO~2~, the INVOS 5100c near-infrared spectrometer (Covidien, Mansfield, Ma USA) was used. The NIRS-determined rScO~2~ was used as an estimator for changes in regional cerebral oxygenation. This measurement provides absolute values, is less sensitive to movement artifacts, and allows for comparison over time. The transducer, containing a light-emitting diode and two distant sensors (i.e., small adult sensor; SAFB-SM, Covidien), was carefully positioned and fixed gently to the frontoparietal surface of the infants head using an elastic band, at the NICU. Differential signals are obtained from these two sensors, and from these signals the rScO~2~ is calculated. The rScO~2~ measures the oxygen saturation of the brain tissue. In a mixture of venous (70--80 %), arterial, and capillary blood the oxygenated hemoglobin (Hb)/total Hb (oxygenated Hb + non-oxygenated Hb) is calculated. Although it still cannot be used as a robust quantitative measurement of cerebral oxygenation, it can serve as a trend monitoring device to detect substantial changes in regional tissue oxygen saturation \[[@CR10]\]. The rScO~2~ was monitored during the entire surgical procedure and continued after the patient had returned to the NICU. Detected rScO~2~ levels are considered within safe reference range in (preterm) neonates when values are between 55 and 85 % \[[@CR11]--[@CR14]\]. When rScO~2~ values exceeded reference limits, anesthetic interventions were made according to our NICU protocol as described by Pellicer et al. and Naulaers et al. \[[@CR15]--[@CR17]\].

Data acquisition {#Sec6}
----------------

Intraoperative hemodynamic parameters and data on rScO~2~, measured by NIRS (INVOS 4100-5100; Covidien, Mansfield, MA, USA), were continuously monitored and stored for offline analysis using locally developed software (BedBase/SignalBase; University Medical Center Utrecht, Utrecht The Netherlands). Data were analyzed during seven intervals that lasted 10 min. These seven time points were as follows: baseline at the NICU ward (T0), directly after anesthesia induction (T1), 30 min after PT CO~2~-insufflation (T2), 30 min before PT CO~2~-exsufflation (T3), and postoperatively at 6 (T4), 12 (T5), and 24 h (T6).

Statistical analysis {#Sec7}
--------------------

Data analysis was performed using IBM SPSS statistics software package (IBM^®^ SPSS^®^ Statistics version 20, IBM Corp. Armonk, NY, USA). Data sets are presented as mean ± SD or as median and range when indicated. The data at different time points was analyzed by related parametric or nonparametric methods as appropriate. When no differences were found in an overall analysis across all seven time points, for clinical reasons, analysis subsequently focused on differences between baseline, anesthesia induction and the initial phases of the surgical procedure. Differences between two time points were analyzed with a Student *t* test. Differences between time points with a *p* value \<0.05 were considered statistically significant.

Results {#Sec8}
=======

Fifteen patients with type C EA (with distal TEF) had complete data registration and were eligible for analysis. Table [1](#Tab1){ref-type="table"} presents demographics and clinical characteristics of the patients in this study. Eight patients had associated comorbidities, of which two patients had a right descending aorta and two patients had non-cyanotic cardiac malformations that required surgical correction at a later stage; one patient with dextrocardia and partial anomalous pulmonary venous connection (PAPVC) and one patient with a malaligned ventricular septal defect with overriding aorta. All patients had an overall uneventful thoracoscopic correction of EA. Median time in the OR was 211 \[126--387\] min, and the median time of PT was 130 \[74--260\] min.Table 1Patient characteristics of 15 patients that had a thoracoscopic correction of an esophageal atresia with tracheoesophageal fistulaClinical characteristics*N* = 15 Gender (M:F)10:5 Gestational age (weeks)39 \[36--42\] Postnatal age at surgery (days)2 \[1--7\] Birth weight (grams)2962 \[2155--4490\]Apgar score After 1 min9 \[4--10\] After 5 min9 \[5--10\]Other comorbidityCor vitium stable hemodynamics 4 No comorbidity *N* = 7Cor vitium requiring later surgery 2 One or more associated anomalies *N* = 8Right descending aorta 2Tracheomalacia 2Duodenal atresia 1Anal atresia 1Vertebrae/rib deformity 5Duration (min) Time on OR211 \[126--387\] Surgery148 \[83--274\] Pneumothorax130 \[74--260\]Data are presented as median \[range\]

Intraoperative hemodynamic and cerebral oxygenation parameters {#Sec9}
--------------------------------------------------------------

Figure [1](#Fig1){ref-type="fig"} summarizes selected perioperative hemodynamic and cerebral oxygenation parameters. All patients remained normothermic during surgery (data not shown). The applied FiO~2~ was 0.68 ± 0.24 at T1 (anesthesia induction), 0.59 ± 0.17 at T2 and 0.49 ± 0.16 at T3 (end of insufflation) (*p* \< 0.05). Median inspiratory Pmax \[range\] was 21 \[14--26\] cmH~2~O at T2 and 20 \[17--28\] cmH~2~O at T3. Median respiratory frequency was 42 \[30--90\] at T2 and 40 \[28--69\] at T3. Changes in MABP were not significant and measurements remained within physiological range (Fig. [1](#Fig1){ref-type="fig"}A). Hypotension was prevented by fluid expansion and administration of dopamine in a range of 1--20 mcg/Kg/min in 10 of 15 (66 %) patients at T2 and to 12 of 15 (80 %) patients at T3. A significant decrease in SaO~2~ was observed at PT application. SaO~2~ decreased from 97 ± 3 % at T0 (baseline) to 90 ± 6 % at T2 (PT application) (*p* \< 0.01). SaO~2~ recovered to normal ranges during the procedure (Fig. [1](#Fig1){ref-type="fig"}B). PaCO~2~ increased from 41 ± 6 mmHg at T0 to 54 ± 15 mmHg at T2 (*p* \< 0.01) and then recovered to normal ranges during the procedure (Fig. [1](#Fig1){ref-type="fig"}C). Arterial sampled pH decreased from 7.33 ± 0.04 at T0 to 7.25 ± 0.11 at T2 (*p* \< 0.05). It then recovered to normal ranges during the procedure (Fig. [1](#Fig1){ref-type="fig"}D). Continuous monitoring of cerebral oxygenation was successful in all 15 neonates. Mean rScO~2~ was significantly higher at T1 compared to T2; 77 ± 10 and 73 ± 7 % respectively (*p* \< 0.05). In none of the neonates, the mean rScO~2~ dropped below the safety threshold of 55 % during or after surgery (Fig. [1](#Fig1){ref-type="fig"}E).Fig. 1**A**--**E** Perioperative physiological parameters and cerebral oxygenation data at baseline (T0), anesthesia induction (T1), 30 min after CO~2~ insufflation (T2), 30 min before ending CO~2~ insufflation (T3) and in the postoperative phase at 6 (T4), 12 (T5), and 24 h (T6). MABP mean arterial blood pressure (**A**), SaO~2~ saturation of peripheral oxygen (**B**), paCO~2~ partial pressure of arterial carbon dioxide (**C**), arterial sampled pH (**D**), rScO~2~ regional cerebral oxygen saturation (**E**). Significant differences are marked *asterisk* and are presented in the figures with Student *t* test *p* values

Discussion {#Sec10}
==========

The aim of this study was to investigate the effects of the installation of a CO~2~ PT on the hemodynamics and cerebral oxygenation of neonates receiving thoracoscopic correction of EA. We observed that surgery with an intrathoracic pressure of 5 mmHg can be performed, while the MABP remains within normal limits. Application of the PT initially lowers SaO~2~, raises paCO~2~, and lowers arterial pH levels. These parameters were corrected through the course of surgery by changes in the ventilation. Under these conditions, cerebral saturation remained within the safety range during the whole procedure. Furthermore, in the postoperative phase cerebral oxygenation and all other monitored parameters remained within normal limits. Our results suggest that a thoracoscopic procedure with a CO~2~ PT set at a pressure of 5 mmHg and flow of 1 L/min can be performed under conditions that allow for reversible arterial blood gas disturbances, with cerebral NIRS values that are elevated during anesthesia induction but that remain stable during and after the PT application.

A large number of pediatric surgical indications can be successfully managed by minimally invasive techniques \[[@CR18]\], especially for cases involving treatment of EA. In an increasing number of pediatric surgical centers, these atresias are managed by thoracoscopic interventions \[[@CR19]\]. Although benefits of either open or thoracoscopic approach to EA surgery remain to be proven in randomized studies \[[@CR20]\], the thoracoscopic approach favors advantages supportive of less postoperative pain, shorter hospital stay \[[@CR21]\], less scoliosis caused by rib fusion, decreased respiratory impairment, and improved overall cosmetic result \[[@CR3], [@CR22], [@CR23]\].

Despite plausible clinical advantages favoring thoracoscopic EA surgery, concerns have been raised regarding the safety of these thoracoscopic interventions in neonates. These concerns focus mostly on the impact of the applied pressurized CO~2~ PT on neonatal hemodynamics and organ perfusion \[[@CR3], [@CR4], [@CR20], [@CR24], [@CR25]\]. Intrathoracic CO~2~ insufflation collapses the lung, which adversely affects the O~2~ and CO~2~ exchange causing hypoxia and hypercarbia. Another factor that causes hypercarbia is the excess systemic CO~2~ load that is absorbed from the thoracic cavity during the PT CO~2~ gas insufflation \[[@CR5]\]. Hypoxia and especially hypercarbia with a lowered pH cause vasodilatation of the cerebral vessels in the neonate \[[@CR26]--[@CR28]\]. When lower arterial oxygen saturation causes lower cerebral oxygen supply, the hypercarbia-induced vasodilatation can compensate for the reduced cerebral oxygen supply if blood pressure remains adequate. Diminished perioperative cerebral oxygen saturation during neonatal cardiothoracic surgery is correlated with poor neurodevelopment outcomes \[[@CR6], [@CR7]\] and brain magnetic resonance imaging abnormalities at 1 year \[[@CR8]\]. Recently, Bishay et al. \[[@CR5]\] reported that severe perioperative hypercarbia, acidosis, and decreased cerebral oxygenation were seen in neonates that underwent thoracoscopic surgery for EA and congenital diaphragmatic hernia. It is proclaimed that the reduction in the cerebral oxygenation lingered for up to 24 h postoperatively. However, in the paper by Bishay et al. \[[@CR5]\] the rScO~2~ value at the start of operation of 87 % was very high, possibly due to initial hyper-oxygenation. It decreased to 75 % at the end of operation. Also in the postoperative phase, cerebral oxygenation levels remained within reference range.

Furthermore, in the published series on neonatal thoracoscopic interventions \[[@CR5], [@CR20]\] that describe the negative impact of CO~2~ application, PT pressures of up to 10 mmHg were applied. A recent experimental study in piglets showed that 10 mmHg PT pressures caused severe hemodynamic instability and decreased cerebral perfusion, whereas these conditions remained stable with PT pressures of 5 mmHg \[[@CR29]\]. The results from this piglet study suggest that the applied pressure of 5 mmHg, as used routinely in our clinic, has no severe adverse effects and seems safe to use in thoracoscopic procedures.

In response to the concerns about thoracoscopic EA surgery, Conforti et al. \[[@CR30]\] concluded that cerebral oxygenation remains stable during open EA correction. The results of our present study show that this conclusion is not exclusively reserved for open EA correction but that it is also possible during thoracoscopic surgery. We believe that close monitoring and a close collaboration between neonatologists, anesthesiologists, and pediatric surgeons is essential for achieving stable physiological conditions with sustained brain oxygenation levels. According to the anesthesia protocol, fluid expansion and inotropes were applied to prevent blood pressure from declining below physiological limits during the thoracoscopic procedure. Moreover, in the present study we observed that in the initial phase of surgery, installation of the PT caused arterial saturation to drop. To allow adequate ventilation, CO~2~ PT insufflation was then stopped until the patient had recovered. If reinstallation of CO~2~ PT persisted in causing low oxygen saturation, insufflation pressures were not increased but an additional trocar was introduced to gently move the lung away from the operating field-of-view. Initial hypercarbia and consequent acidosis was alleviated during the operation by continuous adjustment of ventilator settings. Acceptable limits of perioperative CO~2~ blood gas values are as yet not known \[[@CR2], [@CR31]\]. However, to ascertain CO~2~ and pH levels stayed within acceptable range, adequacy of ventilation is confirmed by arterial blood gas analysis at 30-min intervals \[[@CR20], [@CR30]\].

Whether the initial hypercapnia, which can have strong vasoactive effects \[[@CR2], [@CR26]--[@CR28]\] and the acidosis, recorded in our study, could be detrimental for the developing neonatal brain is unknown \[[@CR31], [@CR32]\]. These blood gas results are comparable though to those seen during open EA surgery. In our study the initial paCO~2~ during the pneumothorax was 54 mmHg. It was 56 mmHg in a series of patients that were operated via (open) thoracotomy in the study by Bishay et al. \[[@CR20]\]. Also, the resulting acidosis in our series with a pH of 7.25 is comparable to a pH of 7.26 in the study of Bishay et al. \[[@CR20]\]. In our study, cerebral oxygenation remained stable and not jeopardized during or after the thoracoscopic procedure. The initial increased cerebral NIRS values prior to the surgical procedure are also described in other studies of open or thoracoscopic neonatal surgery \[[@CR5], [@CR30]\]. This could be a consequence of an increased supply of oxygen at the phase of anesthesia induction. Also in our study the highest median FiO~2~ was recorded at this time (0.68 ± 0.24).

In conclusion, thoracoscopic EA repair can be performed without the need for conversion or extended procedural times with CO~2~-insufflation pressures that are sustained around 5 mmHg. Cerebral oxygenation was stable within the normal range during and after the procedure. Close perioperative monitoring of neonatal brain oxygenation and close collaboration between surgeons, anesthesiologists and neonatologists will remain part of our operative protocol for patients undergoing thoracoscopic reconstruction of EA. Future studies in our institution will focus on the long-term effects of these types of surgery in neonates and the aim of understanding and avoiding impact on the neonatal brain with adverse neurodevelopmental outcomes.
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